Zoetis Inc (ZTS)

NYSE
148.45
-0.15(-0.10%)
  • Volume:
    606,045
  • Day's Range:
    147.77 - 151.14
  • 52 wk Range:
    147.77 - 249.27
Trading near 52-week Low

ZTS Overview

Prev. Close
148.6
Day's Range
147.77-151.14
Revenue
7.89B
Open
149.71
52 wk Range
147.77-249.27
EPS
4.43
Volume
606,045
Market Cap
69.44B
Dividend (Yield)
1.30
(0.87%)
Average Vol. (3m)
1,640,168
P/E Ratio
36.18
Beta
0.721
1-Year Change
-27.42%
Shares Outstanding
468,138,568
Next Earnings Date
Nov 03, 2022
What is your sentiment on Zoetis Inc?
or
Vote to see community's results!

Zoetis Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade
  • Zoetis Misses Q2 EPS by 3c
    • ByInvesting.com-

    Zoetis (NYSE:ZTS) reported Q2 EPS of $1.20, $0.03 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.03...

  • Zoetis Tops Q1 EPS by 8c
    • ByInvesting.com-

    Zoetis (NYSE:ZTS) reported Q1 EPS of $1.32, $0.08 better than the analyst estimate of $1.24. Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.99...

Zoetis Inc Analysis

Zoetis Inc Company Profile

Zoetis Inc Company Profile

Employees
11300

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

Read More

Analyst Price Target

Average225.64 (+51.95% Upside)
High264
Low186
Price148.5
No. of Analysts15
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • I bought in after I was offered the stock because I owned Pfizer years ago. My perspective is different because I bought in at a discount when it was under 30 dollars a share. If it takes a dip, I'll just by more. Either way I'm still have a large ROI.
    0
    • Time to offload this stock.  At least 30% decline coming
      3
      • Everything about this company looks good and I've been in with them since January but their price just can't seem to rise to their potential.  Selling off my shares of this boat anchor.
        3
        • Very intresting Stock. Who bought this?
          0